Biocept SEC Filings

Type
Report
Date
25-NSE25-NSE-Formular11/20/2023
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben8/22/2023
10-QQuartalsbericht8/14/2023

Biocept Documents 2026

This page contains all official documents and SEC filings for Biocept stock (BIOCQ, ISIN: US09072V6002). This includes annual reports (Form 10-K), quarterly reports (Form 10-Q), and insider transactions (Form 4). Currently 3 documents are available. Data is updated regularly to provide investors with a complete overview of Biocept's regulatory filings.